Deborah Weitzman, CEO, Pharmaceutical Segment at CARDINAL HEALTH INC (CAH), sold 73,284 shares at $106.31 ($7.8M) on 2023-11-27, disclosed to the SEC on 2023-11-29.
Scheduled sale ($7.8M) by CEO, Pharmaceutical Segment under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $106.31 | 36,642 | $3.9M | 50.0% |
| 2 | $106.31 | 36,642 | $3.9M | 50.0% |
| Total | $106.31 avg | 73,284 | $7.8M | 100% |
| Filing → |
| CAH | SELL | 2023-08-29 | $1.2M | — | Filing → |